Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia



We constructed a transcutaneous bilirubin (TcB) nomogram to represent major sectors of the Israeli population. We studied the risk of hyperbilirubinemia, defined as meeting the requirements for phototherapy, per percentile risk category.

Study Design:

Newborns 36 weeks gestation were tested daily for TcB, using Drager JM-103 devices, during birth hospitalization. A nomogram was constructed and divided into four risk groups and validated by calculating the need for phototherapy for each group.


A total of 3303 measurements were performed on 1059 consecutive newborns including Ashkenazi, Sephardic and mixed Ashkenazi/Sephardic Jews, Arab and Ethiopian Jewish. Phototherapy risk increased progressively and more than 100-fold, from 0/225 in the <40th percentile group through 27/120 (22.5%) for those >95th percentile (relative risk (95% confidence interval) 102 (6 to 1669) for those >95th percentile compared with those <40th percentile). The optimal risk for discriminating the need for phototherapy was >75th percentile (sensitivity 93.33, specificity 59.47).


The risk of significant hyperbilirubinemia increased progressively with increasing percentile. Newborns >75th percentile groups are at high risk for phototherapy and should be closely monitored.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1


  1. Riskin A, Tamir A, Kugelman A, Hemo M, Bader D . Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? J Pediatr 2008; 152: 782–787.

    Article  CAS  Google Scholar 

  2. Bhutani VK, Johnson L, Sivieri EM . Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6–14.

    Article  CAS  Google Scholar 

  3. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297–316.

    Article  Google Scholar 

  4. Maisels MJ, Kring E . Transcutaneous bilirubin levels in the first 96 h in a normal newborn population of&gt;or=35 weeks' gestation. Pediatrics 2006; 117: 1169–1173.

    Article  Google Scholar 

  5. Fouzas S, Mantagou L, Skylogianni E, Mantagos S, Varvarigou A . Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics 2010; 125: e52–e57.

    Article  Google Scholar 

  6. Akahira-Azuma M, Yonemoto N, Mori R, Hosokawa S, Matsushita T, Sukhbat K et al. An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates. Eur J Pediatr 2015; 174: 1299–1304.

    Article  CAS  Google Scholar 

  7. Kuboi T, Kusaka T, Kawada K, Koyano K, Nakamura S, Okubo K et al. Hour-specific nomogram for transcutaneous bilirubin in Japanese neonates. Pediatr Int 2013; 55: 608–611.

    Article  Google Scholar 

  8. Han S, Yu Z, Liu L, Wang J, Wei Q, Jiang C et alChinese Multicenter Study Coordination Group for Neonatal Hyperbilirubinemia. A model for predicting significant hyperbilirubinemia in neonates from China. Pediatrics 2015; 136: e896–e905.

    Article  Google Scholar 

  9. Engle WD, Lai S, Ahmad N, Manning MD, Jackson GL . An hour-specific nomogram for transcutaneous bilirubin values in term and late preterm Hispanic neonates. Am J Perinatol 2009; 26: 425–430.

    Article  Google Scholar 

  10. Yu ZB, Dong XY, Han SP, Chen YL, Qiu YF, Sha L et al. Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late-preterm Chinese infants. Eur J Pediatr 2011; 170: 185–191.

    Article  CAS  Google Scholar 

  11. Draque CM, Sañudo A, de Araujo Peres C, de Almeida MF . Transcutaneous bilirubin in exclusively breastfed healthy term newborns up to 12 days of life. Pediatrics 2011; 128: e565–e571.

    Article  Google Scholar 

  12. De Luca D, Romagnoli C, Tiberi E, Zuppa AA, Zecca E . Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr 2008; 97: 146–150.

    Article  CAS  Google Scholar 

  13. Bental YA, Shiff Y, Dorsht N, Litig E, Tuval L, Mimouni FB . Bhutani-based nomograms for the prediction of significant hyperbilirubinaemia using transcutaneous measurements of bilirubin. Acta Paediatr 2009; 98: 1902–1908.

    Article  CAS  Google Scholar 

  14. Abu Omar R, Algur N, Megged O, Hammerman C, Kaplan M . Glucose-6-phosphate dehydrogenase screening in Israel-Arab and Palestinian-Arab neonates. J Pediatr 2015; 167: 169–172.

    Article  CAS  Google Scholar 

  15. Kaplan M, Merlob P, Regev R . Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 2008; 28: 389–397.

    Article  CAS  Google Scholar 

  16. Maisels MJ, Deridder JM, Kring EA, Balasubramaniam M . Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 2009; 29: 612–617.

    Article  CAS  Google Scholar 

  17. Mohamed I, Blanchard AC, Delvin E, Cousineau J, Carceller A . Plotting transcutaneous bilirubin measurements on specific transcutaneous nomogram results in better prediction of significant hyperbilirubinemia in healthy term and near-term newborns: a pilot study. Neonatology 2014; 105: 306–311.

    Article  CAS  Google Scholar 

  18. Romagnoli C, Tiberi E, Barone G, De Curtis M, Regoli D, Paolillo P et al. Validation of transcutaneous bilirubin nomogram in identifying neonates not at risk of hyperbilirubinaemia: a prospective, observational, multicenter study. Early Hum Dev 2012; 88: 51–55.

    Article  Google Scholar 

  19. Kaplan M, Bromiker R, Hammerman C . Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity. Semin Perinatol 2014; 38: 429–437.

    Article  Google Scholar 

  20. Raimondi F, Lama S, Landolfo F, Sellitto M, Borrelli AC, Maffucci R et al. Measuring transcutaneous bilirubin: a comparative analysis of three devices on a multiracial population. BMC Pediatr 2012; 12: 70 (1-5).

    Article  CAS  Google Scholar 

  21. Pratesi S, Boni L, Tofani L, Berti E, Sollai S, Dani C . Comparison of the transcutaneous bilirubinometers BiliCare and Minolta JM-103 in late preterm and term neonates. J Matern Fetal Neonatal Med 2016; 29: 3014–3018.

    CAS  PubMed  Google Scholar 

  22. Olusanya BO, Imosemi DO, Emokpae AA . Differences between transcutaneous and serum bilirubin measurements in Black African neonates. Pediatrics 2016; 138: e20160907.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to M Kaplan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bromiker, R., Goldberg, A. & Kaplan, M. Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia. J Perinatol 37, 1315–1318 (2017).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links